The momentum of innate immune cell R and D is growing exponentially to harness innate immune responses and promote gold-standard allogeneic therapies.
Prices:
GBP 1799.00 - GBP 4397.00
URLs:
Website: https://go.evvnt.com/1810491-0?pid=10372
Brochure: https://go.evvnt.com/1810491-3?pid=10372
Speakers
Alex Blyth | Chief Executive Officer | Lift Biosciences, Andre Kunert | Senior Principal Scientist | Kiadis Pharma, Anna-Karin Maltais | Chief Scientific Officer | XNK Therapeutics, Evren Alici | Head of Cell and Gene Therapy Group | Karolinska Institutet, François Gianelli | Head of Regulatory and Quality | TreeFrog Therapeutics, Helgi Van De Velde | Vice President Head Hematologic Malignacies Strategies and Late Development Malignan | Sanofi, Joachim Koch, and more.
Science